Contact dermatitis, adhesive-related redness, itching, and occasional blistering account for the overwhelming majority of reported problems, affecting roughly 10 to 15% of users according to C
3.6 Clinical decision-making: Bayesian probability using weight as an exemplar To address the limitations of binary evidence (i.e., focusing solely on significant vs
reported in a propensity score-matched population-based cohort analysis that GLP-1 receptor agonist use in patients with MASLD and type 2 diabetes was associated with a lower risk of HCC (aHR: 0.55, 95%CI: 0.44-0.69) and all-cause mortality (aHR: 0.62, 95%CI: 0.55-0.71) [59]
Track sulfur burps with Shotsy Sulfur burps often follow patterns that are difficult to see without consistent tracking
Retatrutide: GLP-1 + GIP + Glucagon (Triple Agonist) Retatrutide (LY3437943) keeps the same two receptors as tirzepatide, then adds a third: glucagon
Inject at least two inches from the belly button, rotating positions across the entire abdominal area